BANK VONTOBEL/CALL/NOVARTIS N/96/0.1/20.06.25 Share Price

Warrant

WNOAXV

CH1312985489

Market Closed - Swiss Exchange 16:20:00 17/05/2024 BST
0.54 CHF +5.88% Intraday chart for BANK VONTOBEL/CALL/NOVARTIS N/96/0.1/20.06.25
Current month+35.00%
1 month+92.86%
Date Price Change
17/05/24 0.54 +5.88%
16/05/24 0.51 -8.93%
15/05/24 0.56 -1.75%
14/05/24 0.57 +9.62%
13/05/24 0.52 +4.00%

Delayed Quote Swiss Exchange

Last update May 17, 2024 at 04:20 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer Vontobel Vontobel
WNOAXV
ISINCH1312985489
Date issued 09/01/2024
Strike 96 CHF
Maturity 20/06/2025 (399 Days)
Parity 10 : 1
Emission price 0.43 CHF
Emission volume N/A
Settlement physical
Currency CHF

Technical Indicators

Highest since issue 0.57 CHF
Lowest since issue 0.265 CHF
Spread 0.01 CHF
Spread %1.82%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
102.9 USD
Average target price
108.5 USD
Spread / Average Target
+5.46%
Consensus
  1. Stock Market
  2. Warrants
  3. WNOAXV Warrant